Organisation
Hepatology
Division
The labo of Hepatology studies pathophysiology and treatment of liver and pancreas diseases and metabolism.
Current researchers
1 - 10 of 15 results
- Schalk Van der Merwe (Responsible)
- Isabelle Adant (Member)
- David Cassiman (Member)
- Rita Furtado Feio De Azevedo (Member)
- Hannelie Korf (Member)
- Wim Laleman (Member)
- Louis Libbrecht (Member)
- Frederik Nevens (Member)
- Lukas Van Melkebeke (Member)
- Marc Van de Casteele (Member)
Projects
1 - 10 of 51
- Unravelling aberrant host-microbiota interactions underlying intestinal epithelial barrier failure in cirrhosisFrom7 Feb 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Harnessing single-cell and spatial transcriptomics to uncover novel insights into the pathological events that trigger the progression of acute-on-chronic liver failureFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Deciphering the molecular mechanism that account for intestinal barrier dysfunction in cirrhosisFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Harnessing Single-Cell and Spatial Transcriptomics to Uncover Novel Insights into Intestinal Barrier Breach in CirrhosisFrom1 Oct 2023 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Exploring the molecular mechanisms underlying bacterial translocation in cirrhosisFrom29 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Harnessing single-cell and spatial transcriptomics to uncover novel insights into the pathological events that trigger the progression of acute-on-chronic liver failureFrom1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validation and implementation of a prognostic biomarker of early graft failure after liver transplantation (GlycoTransplantTest)From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Model-informed precision dosing of tacrolimus in solid organ transplant recipientsFrom27 Jul 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Design of robotic catheter and endoscopic systems for cancer treatmentFrom16 Feb 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stratifying risk and individualizing care for patients with clinically significant portal hypertension (CSPH)From7 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 1340
- OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING(2019)
Authors: Stig B Laursen, Adrian J Stanley, Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez, Candido V Sanchez, Dominique Thabut, Luis Ibanez-Samaniego, Javier Martinez, Joan Genesca, et al.
Pages: AB95 - AB95 - LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL(2020)
Authors: Bettina E Hansen, David Jones, Marco Carbone, Christopher L Bowlus, Frederik Nevens, Andreas E Kremer, Alexander Liberman, Leigh MacConell, Gideon M Hirschfield
Pages: 752A - 752A - Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding(2019)
Authors: Stig Borbjerg Laursen, Adrian Stanley, Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez, Lucio Amitrano, Candid Villanueva, Dominique Thabut, Luis Ibanez-Samaniego, Gilberto Silva-Junior, et al.
Pages: E16 - E17 - Elevated alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a multi-center pooled analysis on individual patient data(2014)
Authors: Tom J Gevers, Frederik Nevens, Vicente E Torres, Marie C Hogan, Joost Drenth
Pages: 431A - 431A - HIGH-THROUGHPUT SEQUENCING OF THE HUMAN HEPATIC PROGENITOR CELL NICHE REVEALS DIFFERENT SIGNALLING PATHWAYS DEPENDING ON THE UNDERLYING CHRONIC LIVER DISEASE(2015)
Authors: Olivier Govaere, Jasper Wouters, Wouter Van Delm, R van Eijsden, An Ceulemans, Werner Van Steenbergen, Diethard Monbaliu, Frederik Nevens, Tania Roskams
Pages: S239 - S239 - Increasing the Tolerance for Warm Ischemia of Liver Grafts from DCD Donors by the Leuven Drug Protocol(2011)
Authors: Jos van Pelt, Katrien Vekemans, Diethard Monbaliu, E Balligand, Veerle Heedfeld, Jacques Pirenne
Pages: 437 - 437 - Treatment of Hepatorenal syndrome(2009)
Authors: Frederik Nevens
Pages: 548 - 554 - Hepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium is similar to genotype 1(2010)
Authors: Frederik Nevens
Pages: 229 - 234 - The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.(2014)
Authors: P De Simone, GM Kaiser, L De Carlis, HJ Metselaar, C Duvoux, Frederik Nevens, L Fischer, J Fung, G Dong, B Rauer, et al.
Pages: S106 - S106 - EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL(2013)
Authors: F Saliba, HJ Metselaar, S Beckebaum, C Duvoux, M Navasa, G Dong, P Lopez, Frederik Nevens
Pages: S79 - S80